Samantha is an editor who covers all topics home-related including home improvement and repair. She edited home repair and design content at websites like The Spruce and HomeAdvisor. She also has ...
New phase 2b/3 trial results with MSD's experimental respiratory syncytial virus (RSV) antibody clesrovimab have fired a shot across the bows of AstraZeneca and Sanofi, currently predicting ...
MSD has decided to abandon the development of its anti-TIGIT antibody vibostolimab and anti-LAG-3 antibody favezelimab, blowing a hole in its immuno-oncology pipeline. The demise of the two programmes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback